Board - Patient Focused Medicines Development

PFMD Board

PFMD has from inception been formed as an equal collaboration among its members which includes patient groups, patients, the pharmaceutical industry and regulators. The leadership and governance model adopted by PFMD ensures at least equal or greater share of voice for patient groups. PFMD activities are funded and supported by member organisations.

Nicola Bedlington
Secretary General, European Patients Forum
Veronica Todaro
Vice President, National Programs, Parkinson’s Disease Foundation
Graeme Johnston
Patient Advocate, Individual/ Patient
Alexandra Moutet
Global Head of Patient Affairs, UCB
Andrew Benzie
Andrew Benzie

Head of Patients in Partnership Programme, GSK

Jan Nissen
Jan Nissen

VP, US Regional Customer Operations, Vaccines at Merck

Katherine Capperella
Katherine Capperella

Global Patient Engagement Leader, Janssen

Rebecca Vermeulen
Rebecca Vermeulen

Head Global Medical Liaisons and Communications, Roche

Elisa Ferrer
Elisa Ferrer

Patient Engagement Manager, EURORDIS

Kelli Collins
Kelli Collins

Vice President Patient Engagement, National Kidney Foundation

Lode Dewulf
Lode Dewulf

Chief Patient Officer at Servier Group

Begoña Nafría Escalera
Begoña Nafría Escalera

Patient Engagement in Research Coordinator- Hospital Sant Joan de Déu

Laura McKeaveney
Laura McKeaveney

Global Head of Patient Advocacy at Novartis

Jan Geissler
Jan Geissler

Patient Advocate, EUPATI

Neil Bertelsen
Neil Bertelsen

Chair, HTAi Patient and Citizen Involvement Interest Group

Jim Elliott
Jim Elliott

Public Involvement Lead, Health Research Authority

Esther Krofah
Esther Krofah

Senior Director, FasterCures (a Center of the Milken Institute)

Anthony Yanni
Anthony Yanni

SVP and Global Head, Patient Centricity, Astellas Pharma US

X